NCT01743950 2026-03-25
A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
University of Wisconsin, Madison
Phase 2 Terminated
University of Wisconsin, Madison
European Organisation for Research and Treatment of Cancer - EORTC
Baptist Health South Florida